Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,211 public trials 1,007 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Active, Not Recruiting

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

NCT02864992

Conditions
Adenocarcinoma, Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Bronchial Neoplasms, +13 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • California Cancer Associates for Research & Excellence, Inc. Encinitas, California, United States
  • St. Joseph Hospital Orange, California, United States
  • Torrance Health Association Redondo Beach, California, United States
View all 176 locations
View Trial Details
Active, Not Recruiting

Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)

NCT06577792

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Fujian Provincial Hospital Fuzhou, Fujian, China
  • Gansu Provincial Hospital Lanzhou, Gansu, China
View all 26 locations
View Trial Details
Active, Not Recruiting

A Study of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC

NCT04995523

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
Locations
  • Research Site Chicago, Illinois, United States
  • Research Site Rochester, Minnesota, United States
  • Research Site Fairfax, Virginia, United States
  • Research Site Melbourne, Australia
View all 40 locations
View Trial Details
Active, Not Recruiting

Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination Study

NCT03381274

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site San Francisco, California, United States
  • Research Site Aurora, Colorado, United States
  • Research Site New Haven, Connecticut, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)

NCT03940703

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Yuma Regional Medical Center Yuma, Arizona, United States
  • Compassionate Care Research Group Inc - Edinger Medical Group, Inc. Fountain Valley, California, United States
  • Memorial Care Long Beach, California, United States
  • Ventura County Hematology Oncology Specialists Oxnard, California, United States
View all 179 locations
View Trial Details
Active, Not Recruiting

Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab

NCT04130516

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +29 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States
View Trial Details
Active, Not Recruiting

A Study to Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small Cell Lung Cancer With HER2 Mutations

NCT05048797

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Anchorage, Alaska, United States
  • Research Site Los Alamitos, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Orange, California, United States
View all 130 locations
View Trial Details

Related conditions